Diethylstilbestrol
Active ingredient · 3 therapeutic classes
- Drug class
- Synthetic Estrogens, Plain
- Availability
- See label
- Markets covered
- 1
- Products on record
- 2
Overview
Diethylstilbestrol is an active pharmaceutical ingredient in the Synthetic Estrogens, Plain group (G03CB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 2 | April 10, 2026 |
GBUnited Kingdom· MHRA
2 products
Uses
Diethylstilbestrol tablets are indicated for the treatment of carcinoma of the prostate and metastatic post-menopausal carcinoma of the breast. Diethylstilbestrol is a synthetic non-steroidal oestrogen hormone. It has been in use for many years.
However, due to its carcinogenic potential, the use of Diethylstilbestrol is now only justified in the management of malignant disease. It may be used to suppress androgenic hormonal activity in the management of androgen¬dependent carcinomas such as carcinoma of the prostate in males and some post-menopausal carcinomas such as breast cancer in females.
How to take
Drug interactions
Known interactions involving Diethylstilbestrol. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL002895188 · revised April 10, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.